The nation of Zimbabwe has rejected a significant American healthcare agreement worth $367m (272 million pounds) spanning five years over Washington's demand for sensitive data.
This rejection became public following a official document dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "lopsided".
A government spokesman later explained that the US was seeking health data for scientific study and commercial purposes while was not willing to guarantee the resulting advantages from any future vaccines.
"We will now turn to the challenging and unfortunate process of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had donated more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged more dialogue to secure a agreement agreeable to both sides so the nation's critical HIV programme can be sustained.
Broader Implications
Zimbabwe's decision comes after a comparable case in Kenya, where a high court suspended a related deal with the US following legal challenges were raised about the security of citizens' medical information.
Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
The agency had managed assistance for the American government, but Trump argued its spending was "wasteful" and his government was seeking direct bilateral deals to boost transparency and responsibility.
Based on reports, Sixteen nations in Africa have to date agreed to similar agreements, representing more than $18.3bn of fresh investment.
Details of the Declined Agreement
The funds for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million currently on HIV treatment through American-funded programmes," Tremont added.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to surrender its genetic material and health information over an extended period, with no corresponding promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might be developed from that shared data," Mangwana explained.
"In essence, our country would provide the raw materials for medical research without any certainty that the end products would be available to our citizens if a future pandemic emerge."
National Interest and International Frameworks
Mangwana further noted that the American exit from the global health body and its pursuit of bilateral deals were upending structures already set up via the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to manage future global health emergencies.
"This framework is designed to ensure that when a country contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We are open to continued dialogue with our US partners on how subsequent co-operation could be structured in a manner that respects the sovereignty and dignity of each country."
Health Experts Response
Medical experts said it acknowledged the official position, but recommended that talks need to persist since much of the country's Aids initiatives relied on foreign aid.
"If technical issues arise, such as those involving information security or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," the group added.
The situation underscores the continuing challenges between accepting crucial international aid and safeguarding national sovereignty in an increasingly data-driven world.